175 related articles for article (PubMed ID: 35731709)
1. Essential Role of Enzymatic Activity in the Leishmanicidal Mechanism of the Eosinophil Cationic Protein (RNase 3).
Abengózar MÁ; Fernández-Reyes M; Salazar VA; Torrent M; de la Torre BG; Andreu D; Boix E; Rivas L
ACS Infect Dis; 2022 Jul; 8(7):1207-1217. PubMed ID: 35731709
[TBL] [Abstract][Full Text] [Related]
2. Role of unique basic residues in cytotoxic, antibacterial and antiparasitic activities of human eosinophil cationic protein.
Singh A; Batra JK
Biol Chem; 2011 Apr; 392(4):337-46. PubMed ID: 21303303
[TBL] [Abstract][Full Text] [Related]
3. Mapping the eosinophil cationic protein antimicrobial activity by chemical and enzymatic cleavage.
Sánchez D; Moussaoui M; Carreras E; Torrent M; Nogués V; Boix E
Biochimie; 2011 Feb; 93(2):331-8. PubMed ID: 20951760
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the membrane interaction mechanism of two antimicrobial RNases: RNase 3/ECP and RNase 7.
Torrent M; Sánchez D; Buzón V; Nogués MV; Cladera J; Boix E
Biochim Biophys Acta; 2009 May; 1788(5):1116-25. PubMed ID: 19366593
[TBL] [Abstract][Full Text] [Related]
5. Eosinophil cationic protein (ECP) can bind heparin and other glycosaminoglycans through its RNase active site.
Torrent M; Nogués MV; Boix E
J Mol Recognit; 2011; 24(1):90-100. PubMed ID: 20213669
[TBL] [Abstract][Full Text] [Related]
6. Ribonuclease activity associated with human eosinophil-derived neurotoxin and eosinophil cationic protein.
Slifman NR; Loegering DA; McKean DJ; Gleich GJ
J Immunol; 1986 Nov; 137(9):2913-7. PubMed ID: 3760576
[TBL] [Abstract][Full Text] [Related]
7. Bactericidal and membrane disruption activities of the eosinophil cationic protein are largely retained in an N-terminal fragment.
Torrent M; de la Torre BG; Nogués VM; Andreu D; Boix E
Biochem J; 2009 Jul; 421(3):425-34. PubMed ID: 19450231
[TBL] [Abstract][Full Text] [Related]
8. The cytotoxic eosinophil cationic protein (ECP) has ribonuclease activity.
Gullberg U; Widegren B; Arnason U; Egesten A; Olsson I
Biochem Biophys Res Commun; 1986 Sep; 139(3):1239-42. PubMed ID: 3768000
[TBL] [Abstract][Full Text] [Related]
9. Eosinophil cationic protein/RNase 3 is another RNase A-family ribonuclease with direct antiviral activity.
Domachowske JB; Dyer KD; Adams AG; Leto TL; Rosenberg HF
Nucleic Acids Res; 1998 Jul; 26(14):3358-63. PubMed ID: 9649619
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial activity of human eosinophil granule proteins: involvement in host defence against pathogens.
Malik A; Batra JK
Crit Rev Microbiol; 2012 May; 38(2):168-81. PubMed ID: 22239733
[TBL] [Abstract][Full Text] [Related]
11. Eosinophil ribonucleases and their cutaneous lesion-forming activity.
Plager DA; Davis MD; Andrews AG; Coenen MJ; George TJ; Gleich GJ; Leiferman KM
J Immunol; 2009 Sep; 183(6):4013-20. PubMed ID: 19717523
[TBL] [Abstract][Full Text] [Related]
12. Ribonuclease activity and substrate preference of human eosinophil cationic protein (ECP).
Sorrentino S; Glitz DG
FEBS Lett; 1991 Aug; 288(1-2):23-6. PubMed ID: 1715291
[TBL] [Abstract][Full Text] [Related]
13. The cytotoxicity of eosinophil cationic protein/ribonuclease 3 on eukaryotic cell lines takes place through its aggregation on the cell membrane.
Navarro S; Aleu J; Jiménez M; Boix E; Cuchillo CM; Nogués MV
Cell Mol Life Sci; 2008 Jan; 65(2):324-37. PubMed ID: 18087674
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial activity of human eosinophil granule proteins.
Chopra A; Batra JK
Methods Mol Biol; 2014; 1178():267-81. PubMed ID: 24986624
[TBL] [Abstract][Full Text] [Related]
15. Towards the rational design of antimicrobial proteins: single point mutations can switch on bactericidal and agglutinating activities on the RNase A superfamily lineage.
Pulido D; Moussaoui M; Nogués MV; Torrent M; Boix E
FEBS J; 2013 Nov; 280(22):5841-52. PubMed ID: 23992292
[TBL] [Abstract][Full Text] [Related]
16. Mouse eosinophil associated ribonucleases: Mechanism of cytotoxic, antibacterial and antiparasitic activities.
Attery A; Batra JK
Int J Biol Macromol; 2017 Jan; 94(Pt A):445-450. PubMed ID: 27765572
[TBL] [Abstract][Full Text] [Related]
17. Comparative toxicity of purified human eosinophil granule cationic proteins for schistosomula of Schistosoma mansoni.
Ackerman SJ; Gleich GJ; Loegering DA; Richardson BA; Butterworth AE
Am J Trop Med Hyg; 1985 Jul; 34(4):735-45. PubMed ID: 4025686
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of eosinophil cationic protein at 2.4 A resolution.
Boix E; Leonidas DD; Nikolovski Z; Nogués MV; Cuchillo CM; Acharya KR
Biochemistry; 1999 Dec; 38(51):16794-801. PubMed ID: 10606511
[TBL] [Abstract][Full Text] [Related]
19. The antipathogen activities of eosinophil cationic protein.
Boix E; Torrent M; Sánchez D; Nogués MV
Curr Pharm Biotechnol; 2008 Jun; 9(3):141-52. PubMed ID: 18673279
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial Activity of Human Eosinophil Granule Proteins.
Chopra A; Batra JK
Methods Mol Biol; 2021; 2241():257-274. PubMed ID: 33486742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
